Calling scientific and technological innovation the ‘main battlefield of international strategic competition’, agriculture ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, continues to make good progress in 2025 with key regulatory and ...

Biotech continues to make good progress in 2025 with key regulatory and clinical advancements, reinforcing pelareorep’s ...

Jill Collins, CEO, Chief Strategy Officer, Audacity Health.

Key developments include breakthroughs in biopharmaceuticals, agricultural biotechnology, and environmental sustainability ... and services driven by biological sciences to develop new technologies, ...

It involves disciplines such as biology, biotechnology ... processes and organisms to improve human health, develop new therapies, and solve pressing challenges across various industries. With ...

Virginia Tech is leading the effort that aims to strengthen bonds between biomedical companies and sector leaders.

While advancements in biotechnology hold immense promise for health and innovation, they also come with significant risks if ...

really taking new ideas and putting them into people ... such as Virginia Tech with leaders in the biotech sector, supporting advancements in surgical technology and medical manufacturing.

Rezolute , Inc. (NASDAQ:RZLT), a clinical-stage biopharmaceutical company, is making significant strides in the development of its lead drug candidate, ersodetug, for the treatment of congenital ...

While billions pour into pharmaceutical biotech, officials and experts warn there’s much less private investment in products more relevant to the military, like body armor materials, anti-corrosion ...

Growth in the biotechnology market is fueled by advances in diagnostics, gene editing, and monoclonal antibodies as well as an increase in the need for new medications and vaccines. Nonetheless ...